Multi-omics reveals key molecular and cellular features of advanced small cell lung cancers associated with distinct therapeutic opportunities

We showed that methylation of the most common source of tumor tissue in the clinical setting can stratify SCLCs with distinct clinical outcomes and potentially tailored therapeutic options. Methylation can characterize the intrinsic and extrinsic heterogeneity of SCLCs and fuel the discovery of novel therapeutic vulnerabilities to help bridge the gap between research and clinical application to improve care for SCLC patients.

Authors

Institutions

Publication Details

Journal
Genome Medicine
Published
2026-03-17
DOI
https://doi.org/10.1186/s13073-026-01624-y
Primary Topic
Lung Cancer Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multi-omics reveals key molecular and cellular features of advanced small cell lung cancers associated with distinct therapeutic opportunities

David Fielding, Nicola Waddell, Carl Pahoff, Andrew J. Dalley et al.
Genome Medicine
Lung Cancer Research Studies
article

Multi-omics reveals key molecular and cellular features of advanced small cell lung cancers associated with distinct therapeutic opportunities

David Fielding, Nicola Waddell, Carl Pahoff, Andrew J. Dalley, Vanessa Lakis, Christopher Grainge, Jemma J. Christie, Scott Twaddell, Jonathan Williamson, Shailendra Gune, John V. Pearson, Lakshmy Nandakumar, Conrad Leonard, Jung Hwa Son, Daniel Steinfort, Felicity Newell, Lambros T. Koufariotis, Farzad Bashirzadeh, Kimberley Ryan, Haarika Chittoory, Margaret C. Cummings, Kate Fitzgerald, Jelena Solujic, L. McIntosh, Kaltin Ferguson, Michael S. Brown, David Arnold, Sunil R. Lakhani, Katia Nones, Mahendra Singh, David Fairbairn, Oliver Holmes, Peter T. Simpson, Matthew Gibney, Phan Tien Nguyen, Scott Wood, Andrew Pattison
article en

Abstract

We showed that methylation of the most common source of tumor tissue in the clinical setting can stratify SCLCs with distinct clinical outcomes and potentially tailored therapeutic options. Methylation can characterize the intrinsic and extrinsic heterogeneity of SCLCs and fuel the discovery of novel therapeutic vulnerabilities to help bridge the gap between research and clinical application to improve care for SCLC patients.

Genome Medicine
Royal Adelaide Hospital (AU), The Royal Melbourne Hospital (AU), Queensland University of Technology (AU), The University of Queensland (AU), The University of Melbourne (AU), QIMR Berghofer Medical Research Institute (AU), Royal Brisbane and Women's Hospital (AU), Gold Coast Hospital (AU), John Hunter Hospital (AU), Liverpool Hospital (AU), Sunshine Coast University Hospital (AU)
Good health and well-being
Openalex Percentile: Top 19%
Lung Cancer Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.